(Q34105143)

31 July 2017

1 reference

title

Yohimbine: a clinical review (English)

1 reference

31 July 2017

Tam SW

1

1 reference

PubMed ID

11744068

31 July 2017

Worcel M

series ordinal

2

1 reference

PubMed ID

11744068

31 July 2017

Wyllie M

series ordinal

3

1 reference

31 July 2017

1 September 2001

1 reference

Pharmacology & Therapeutics

31 July 2017

1 reference

31 July 2017

91

1 reference

31 July 2017

3

1 reference

31 July 2017

215-243

1 reference

Yohimbine impairs P50 auditory sensory gating in normal subjects.

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Enhanced alpha-adrenoreceptor-mediated vasoconstriction in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Effect of systemic alpha-2 adrenergic blockade on the morning increase in platelet aggregation in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Is yohimbine-induced increase in salivary secretion a kinin-dependent mechanism?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Effect of 3 weeks treatment with yohimbine on salivary secretion in healthy volunteers and in depressed patients treated with tricyclic antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Pharmacokinetic study of yohimbine and its pharmacodynamic effects on salivary secretion in patients treated with tricyclic antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Evidence for activation of both adrenergic and cholinergic nervous pathways by yohimbine, an alpha 2-adrenoceptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

A comparative study of the effects of yohimbine and anetholtrithione on salivary secretion in depressed patients treated with psychotropic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Alpha 2-adrenoceptor antagonist potencies of two hydroxylated metabolites of yohimbine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

The alpha 2-adrenergic receptor antagonist yohimbine inhibits epinephrine-induced platelet aggregation in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Manipulation of norepinephrine metabolism with yohimbine in the treatment of autonomic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

A pilot study of oral physostigmine plus yohimbine in patients with Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

In vivo studies on alpha-adrenergic receptor subtypes in human veins

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Hypersensitivity of adrenergic receptors and blood-pressure response to oral yohimbine in orthostatic hypotension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Hormone-fuel interrelationships during fasting

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Yohimbine augmentation of fluvoxamine in refractory depression: a single-blind study.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Effectiveness of yohimbine in the treatment of erectile disorder: four meta-analytic integrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Assessment of α2 adrenergic autoreceptor function in humans: Effects of oral yohimbine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Behavioral, biochemical, and blood pressure responses to alprazolam in healthy subjects: interactions with yohimbine.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Desipramine-yohimbine combination treatment of refractory depression. Implications for the beta-adrenergic receptor hypothesis of antidepressant action

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Noradrenergic function in generalized anxiety disorder: effects of yohimbine in healthy subjects and patients with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Yohimbine increases human salivary secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Catecholamines contribute to exertional dyspnoea and to the ventilatory response to exercise in normal humans

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Enhancement of sexual motivation in male rats by yohimbine.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Effects of alpha-2 adrenoreceptor blockade by yohimbine on the hormonal response to hypoglycaemic stress in normal man

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

The effect of yohimbine on sympathetic responsiveness in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Patterns of messenger RNA expression for alpha1-adrenoceptor subtypes in human corpus cavernosum.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

YOHIMBINE FOR ERECTILE DYSFUNCTION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Benign course after massive ingestion of yohimbine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Alpha 2-antagonist compounds and lipid mobilization: evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Pharmacodynamic effects of chronic yohimbine treatment in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Enhancement of morphine analgesia by the alpha 2-adrenergic antagonist yohimbine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Effect of clonidine and yohimbine on sleep in healthy men: a double-blind, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Influence of yohimbine on blood pressure, autonomic reflexes, and plasma catecholamines in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Effects of yohimbine on autonomic measures are determined by individual values for area under the concentration-time curve.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Oral yohimbine increases blood pressure and sympathetic nervous outflow in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

The expression of functional postsynaptic alpha2-adrenoceptors in the corpus cavernosum smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Effect of yohimbine on plasma homovanillic acid in panic disorder patients and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Yohimbine bioavailability in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Dose Dependent Effects of Yohimbine on Methadone Maintained Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Comparison of the antagonistic activity of tamsulosin and doxazosin at vascular alpha 1-adrenoceptors in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Yohimbine pharmacokinetics and interaction with the sympathetic nervous system in normal volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

alpha 2-Adrenergic receptor sensitivity in depression. The plasma MHPG, behavioral, and cardiovascular responses to yohimbine.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Changes in semen quality and fertility in response to endocrine treatment of subfertile men

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Transient impairment in P50 auditory sensory gating induced by a cold-pressor test.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: a large-scale retrospective study of 596 psychiatric outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

A randomized crossover study using yohimbine and isoxsuprine versus pentoxifylline in the management of vasculogenic impotence

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Dose-response relationship for oral idazoxan effects in healthy human subjects: comparison with oral yohimbine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Evidence of acoustic startle hyperreflexia in recently detoxified early onset male alcoholics: modulation by yohimbine and m-chlorophenylpiperazine (mCPP).

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Is high-dose yohimbine hydrochloride effective in the treatment of mixed-type impotence? A prospective, randomized, controlled double-blind crossover study.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Effect of yohimbine on blood pressure in patients with depression and orthostatic hypotension induced by clomipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Fasting, Feeding and Regulation of the Sympathetic Nervous System

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Cerebrospinal fluid and plasma disposition of yohimbine and 11-hydroxy-yohimbine in young and older healthy subjects, and Alzheimer's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Biopharmaceutics and metabolism of yohimbine in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Determination of yohimbine and its two hydroxylated metabolites in humans by high-performance liquid chromatography and mass spectral analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Partial reversal of the effects of extradural clonidine by oral yohimbine in postoperative patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Yohimbine: a new street drug

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Yohimbine and aldosterone responsiveness to angiotensin II or corticotrophin in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Effects of yohimbine on sexual experiences and nocturnal penile tumescence and rigidity in erectile dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Anxiogenic effect of yohimbine in healthy subjects: comparison with caffeine and antagonism by clonidine and diazepam.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Noradrenergic response to acute ethanol administration in healthy subjects: comparison with intravenous yohimbine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Differential effects of noradrenergic drugs on anxiety and arousal in healthy volunteers with high and low anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Effects of yohimbine on submaxillary salivation in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Effect of yohimbine-trazodone on psychogenic impotence: A randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Is yohimbine effective in the treatment of organic impotence? Results of a controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Yohimbine-facilitated acoustic startle reflex in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Yohimbine facilitated acoustic startle in combat veterans with post-traumatic stress disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Effects of clonidine and yohimbine on the pupillary light reflex and carbachol-evoked sweating in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Yohimbine in neurally mediated syncope. Pathophysiological implications

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Effects of Yohimbine on Human Sympathetic Nervous System Function*

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Yohimbine effects on blood pressure and plasma catecholamines in human hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Yohimbine and pentoxifylline in the treatment of erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Stimulation of the noradrenergic system enhances and blockade reduces memory for emotional material in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

[Shy-Drager syndrome: a rare cause of orthostatic hypotension]

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Oral yohimbine in human autonomic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

The pharmacokinetics of yohimbine in man

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Yohimbine increases cerebrospinal fluid and plasma norepinephrine but not arginine vasopressin in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Effects of Alzheimer's disease and normal aging on cerebrospinal fluid norepinephrine responses to yohimbine and clonidine.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Cerebrospinal fluid epinephrine in Alzheimer's disease and normal aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Increased plasma norepinephrine response to yohimbine in elderly men

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Plasma MHPG response to yohimbine treatment in women with hypoactive sexual desire.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Adjunctive yohimbine for treatment in refractory depression

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Three cases of manic symptoms following yohimbine administration

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Effects of yohimbine in obsessive compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Plasma neuropeptide Y (NPY) increases in humans in response to the alpha 2 antagonist yohimbine.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Double-blind trial of yohimbine in treatment of psychogenic impotence.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Involvement of a central nervous pathway in yohimbine-induced insulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Use of alpha 2 adrenoreceptor agonists and antagonists in the functional assessment of the sympathetic nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Reversal of sexual exhaustion by serotonergic and noradrenergic agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Yohimbine, erectile capacity, and sexual response in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Treatment of drug-induced anorgasmia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Effects of yohimbine on plasma catecholamine levels in orthostatic hypotension related to Parkinson disease or multiple system atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Prejunctional alpha 2-adrenoceptors inhibit nitrergic neurotransmission in horse penile resistance arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Alpha 2-adrenoceptor antagonists and male sexual behavior: I. Mating behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Alpha 2-adrenoceptor antagonists and male sexual behavior: II. Erectile and ejaculatory reflexes.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

The role of yohimbine for the treatment of erectile impotence

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Noradrenergic and serotonergic function in posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Some pharmacologic effects of yohimbine on human and rabbit penis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Yohimbine elimination in normal volunteers is characterized by both one- and two-compartment behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

The Production and Metabolism of 3,5,3′-Triiodothyronine and 3,3′,5′-Triiodothyronine in Normal and Fasting Subjects*

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Effect of yohimbine hydrochloride on erectile impotence: a double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Therapeutic effects of high dose yohimbine hydrochloride on organic erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

A heterogeneous population of alpha 1 adrenergic receptors mediates contraction of human corpus cavernosum smooth muscle to norepinephrine.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Lipomobilizing effects of procaterol and yohimbine in the conscious dog: comparison of endocrinological, metabolic and cardiovascular effects

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Overdose of yohimbine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Effects of yohimbine, an alpha 2-adrenoceptor antagonist, on experimental neurogenic orthostatic hypotension.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Double-blind, placebo-controlled safety and efficacy trial with yohimbine hydrochloride in the treatment of nonorganic erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Cardiovascular effects of ephedrine, caffeine and yohimbine measured by thoracic electrical bioimpedance in obese women

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Yohimbine and sinusitis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

Biphasic effects of yohimbine on the ejaculatory response in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900156-5

7 January 2021

10.1016/S0163-7258(01)00156-5

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11744068